Posted by Editoress on 05/8/08
Cycling Athlete Commits Anti-Doping Rule Violation
Press release CCES
The Canadian Centre for Ethics in Sport (CCES) announced today that a BMX cycling athlete has committed an anti-doping rule violation. The violation occurred during in-competition doping control on June 30, 2007.
The anti-doping rule violation is a result of the athletes urine sample returning an adverse analytical finding for cannabis, a prohibited substance on the World Anti-Doping Agency (WADA) Prohibited List. Cannabinoids are classified as specified substances on the Prohibited List. Specified substances are those substances which are generally available in medicinal products or are less likely to be abused as doping agents.
Under the rules of the Canadian Anti-Doping Program (CADP), when an athlete can establish that a first anti-doping rule violation involving a specified substance was not intended to enhance his / her sport performance, the sanction may range from a reprimand and warning to a one-year period of ineligibility.
In response to the CCES notification of the adverse analytical finding, the athlete exercised the right to a hearing under the rules of the CADP. The independent arbitrator determined that the athletes adverse analytical finding constitutes an anti-doping rule violation, and imposed a sanction of a warning and reprimand and no period of ineligibility.
Rule 7.15 of the CADP requires the CCES to publicly report the final decision on all anti-doping rule violations. In accordance with the CCES Policy on Public Disclosure of Anti-Doping Rule Violations, since this violation has resulted in a warning and reprimand and no period of ineligibility, the CCES will not disclose the athletes name.
The CCES is an independent, national, non-profit organization. Our mission, to foster ethical sport for all Canadians, is carried out through research, promotion, education, detection and deterrence, as well as through programs and partnerships with other organizations.
|Return to Canadian Cyclist homepage | Back to Top|